Seiki Wada

2.5k total citations
58 papers, 1.6k citations indexed

About

Seiki Wada is a scholar working on Oncology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Seiki Wada has authored 58 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 23 papers in Molecular Biology and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Seiki Wada's work include Bone health and treatments (20 papers), Bone Metabolism and Diseases (14 papers) and Bone health and osteoporosis research (7 papers). Seiki Wada is often cited by papers focused on Bone health and treatments (20 papers), Bone Metabolism and Diseases (14 papers) and Bone health and osteoporosis research (7 papers). Seiki Wada collaborates with scholars based in Japan, Australia and United States. Seiki Wada's co-authors include Shigehiro Katayama, David M. Findlay, T. John Martin, Masakazu Kogawa, Masahito Matsumoto, Koji Hisatake, Masafumi Tsujimoto, Nobuyuki Udagawa, Hiroshi Takayanagi and Yasuhisa Nogi and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Seiki Wada

55 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seiki Wada Japan 18 963 642 270 239 205 58 1.6k
J.A. Gallagher United Kingdom 28 1.2k 1.3× 569 0.9× 205 0.8× 154 0.6× 115 0.6× 79 2.6k
Keertik Fulzele United States 17 997 1.0× 524 0.8× 174 0.6× 299 1.3× 153 0.7× 37 1.9k
Lingling Xian United States 17 805 0.8× 424 0.7× 269 1.0× 92 0.4× 122 0.6× 31 1.5k
Ingrid J. Poulton Australia 26 1.2k 1.3× 855 1.3× 160 0.6× 127 0.5× 564 2.8× 47 2.2k
Chohei Shigeno Japan 26 1.1k 1.1× 598 0.9× 154 0.6× 121 0.5× 71 0.3× 71 2.0k
Masanori Kanatani Japan 25 896 0.9× 607 0.9× 119 0.4× 267 1.1× 50 0.2× 39 1.7k
Riku Kiviranta Finland 24 1.2k 1.2× 519 0.8× 273 1.0× 68 0.3× 116 0.6× 47 1.8k
Weiqi Lei United States 10 805 0.8× 429 0.7× 154 0.6× 65 0.3× 197 1.0× 11 1.6k
S. C. Manolagas United States 10 1.3k 1.3× 837 1.3× 155 0.6× 186 0.8× 175 0.9× 14 2.2k
Yasuto Taguchi United States 10 668 0.7× 431 0.7× 96 0.4× 73 0.3× 99 0.5× 10 1.1k

Countries citing papers authored by Seiki Wada

Since Specialization
Citations

This map shows the geographic impact of Seiki Wada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seiki Wada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seiki Wada more than expected).

Fields of papers citing papers by Seiki Wada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seiki Wada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seiki Wada. The network helps show where Seiki Wada may publish in the future.

Co-authorship network of co-authors of Seiki Wada

This figure shows the co-authorship network connecting the top 25 collaborators of Seiki Wada. A scholar is included among the top collaborators of Seiki Wada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seiki Wada. Seiki Wada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yasuda, S., Seiki Wada, Shinjiro Kono, et al.. (2013). Tumor-induced osteomalacia: benign tumor recurrence after two surgical resections at two different medical institutions. Endocrine Practice. 19(4). 97–101. 3 indexed citations
3.
Wada, Seiki, Takeshi Fukawa, & Sadahiro Kamiya. (2009). [Biochemical markers of bone turnover. New aspect. Bone metabolic markers available in daily practice].. PubMed. 19(8). 1075–82. 2 indexed citations
4.
Wada, Seiki, Takeshi Fukawa, & Sadahiro Kamiya. (2007). [Osteocalcin and bone].. PubMed. 17(11). 1673–7. 13 indexed citations
5.
Kamiya, Sadahiro, Chika Nakamura, Takeshi Fukawa, et al.. (2007). Effects of IL-23 and IL-27 on osteoblasts and osteoclasts: inhibitory effects on osteoclast differentiation. Journal of Bone and Mineral Metabolism. 25(5). 277–285. 71 indexed citations
6.
Wada, Seiki & Sadahiro Kamiya. (2006). [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Osteocalcin (OC)].. PubMed. 16(6). 1017–21. 11 indexed citations
7.
Yasuda, S. & Seiki Wada. (2006). [Diabetic osteopahty and vitamin K].. PubMed. 16(8). 1351–57.
8.
Ono, Katsuhiro & Seiki Wada. (2004). [Regulation of calcification by bisphosphonates].. PubMed. 14(6). 60–3. 6 indexed citations
9.
Kamiya, Sadahiro, Tatsuya Kawaguchi, Naoko Kamiya, et al.. (2004). A fibronectin fragment induces tumor necrosis factor production of rat basophilic leukemia cells. Biochimica et Biophysica Acta (BBA) - General Subjects. 1675(1-3). 87–94. 3 indexed citations
11.
Minagawa, Akinobu, Makoto Iitaka, Miho Suzuki, et al.. (2002). A case of primary mucoepidermoid carcinoma of the thyroid: molecular evidence of its origin. Clinical Endocrinology. 57(4). 551–556. 38 indexed citations
13.
Iitaka, Makoto, et al.. (1998). Increased Serum Vascular Endothelial Growth Factor Levels and Intrathyroidal Vascular Area in Patients with Graves’ Disease and Hashimoto’s Thyroiditis. The Journal of Clinical Endocrinology & Metabolism. 83(11). 3908–3912. 98 indexed citations
14.
Ono, Kohei, Takuhiko Akatsu, Takehiko Murakami, et al.. (1998). Mouse Mammary Carcinoma Cell Line (BALB/c-MC) Stimulates Osteoclast Formation From Mouse Bone Marrow Cells Through Cell-to-Cell Contact. Bone. 23(1). 27–32. 13 indexed citations
15.
Kado, Seijiro, Seiki Wada, Yasuyuki Katayama, et al.. (1996). Urinary type IV collagen as a marker for early diabetic nephropathy. Diabetes Research and Clinical Practice. 31(1-3). 103–108. 36 indexed citations
16.
Udagawa, Nobuyuki, N. Takahashi, Takashi Katagiri, et al.. (1995). Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors.. The Journal of Experimental Medicine. 182(5). 1461–1468. 334 indexed citations
17.
Wada, Seiki, T. John Martin, & David M. Findlay. (1995). Homologous regulation of the calcitonin receptor in mouse osteoclast-like cells and human breast cancer T47D cells.. Endocrinology. 136(6). 2611–2621. 42 indexed citations
18.
Wada, Seiki, et al.. (1991). The effect of PGF2α on parathyroid hormone-stimulated cyclic AMP production in mouse osteoblastic cell, MC3T3E1. Biochimica et Biophysica Acta (BBA) - General Subjects. 1074(1). 182–188. 9 indexed citations
19.
Kugai, Nobuo, Naokazu Nagata, Takuhiko Akatsu, et al.. (1990). Inhibition of renal membrane adenylate cyclase by extract of pancreatic cancer associated with humoral hypercalcemia of malignancy. Bone and Mineral. 9(2). 111–120. 3 indexed citations
20.
Yamaguchi, Tatsuro, Seiki Wada, & Y Matsukado. (1983). [Intracranial giant osteochondroma with unusual clinical features].. PubMed. 11(2). 181–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026